Chemoinformaics analysis of 18-DEOXYSAGITTAROL
| Molecular Weight | 290.491 | nRot | 4 |
| Heavy Atom Molecular Weight | 256.219 | nRig | 12 |
| Exact Molecular Weight | 290.261 | nRing | 2 |
| Solubility: LogS | -5.203 | nHRing | 0 |
| Solubility: LogP | 5.178 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 56.873 |
| nHD | 1 | BPOL | 34.109 |
| QED | 0.678 |
| Synth | 4.556 |
| Natural Product Likeliness | 3.358 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.627 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.533 |
| MDCK | 0.0000114 |
| BBB | 0.177 |
| PPB | 0.977021 |
| VDSS | 1.103 |
| FU | 0.0390012 |
| CYP1A2-inh | 0.055 |
| CYP1A2-sub | 0.483 |
| CYP2c19-inh | 0.268 |
| CYP2c19-sub | 0.947 |
| CYP2c9-inh | 0.211 |
| CYP2c9-sub | 0.397 |
| CYP2d6-inh | 0.193 |
| CYP2d6-sub | 0.389 |
| CYP3a4-inh | 0.895 |
| CYP3a4-sub | 0.58 |
| CL | 10.671 |
| T12 | 0.074 |
| hERG | 0.008 |
| Ames | 0.006 |
| ROA | 0.039 |
| SkinSen | 0.506 |
| Carcinogencity | 0.055 |
| EI | 0.791 |
| Respiratory | 0.135 |
| NR-Aromatase | 0.548 |
| Antiviral | No |
| Prediction | 0.744623 |